178 related articles for article (PubMed ID: 22392075)
1. Loco-recurrence after resection for ductal adenocarcinoma of the pancreas: predictors and implications for adjuvant chemoradiotherapy.
Zhang Y; Frampton AE; Kyriakides C; Bong JJ; Habib N; Ahmad R; Jiao LR
J Cancer Res Clin Oncol; 2012 Jun; 138(6):1063-71. PubMed ID: 22392075
[TBL] [Abstract][Full Text] [Related]
2. Mapping patterns of local recurrence after pancreaticoduodenectomy for pancreatic adenocarcinoma: a new approach to adjuvant radiation field design.
Dholakia AS; Kumar R; Raman SP; Moore JA; Ellsworth S; McNutt T; Laheru DA; Jaffee E; Cameron JL; Tran PT; Hobbs RF; Wolfgang CL; Herman JM
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1007-15. PubMed ID: 24267969
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant Therapy in Pancreas Cancer: Does It Influence Patterns of Recurrence?
Parikh AA; Maiga A; Bentrem D; Squires MH; Kooby DA; Maithel SK; Weber SM; Cho CS; Katz M; Martin RC; Scoggins CR; Sutton J; Ahmad SA; Abbott DE; Carr J; Kim HJ; Yakoub D; Idrees K; Merchant N
J Am Coll Surg; 2016 Apr; 222(4):448-56. PubMed ID: 26895735
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of completion pancreatectomy for recurrence of adenocarcinoma in the remnant pancreas.
Nakayama Y; Sugimoto M; Gotohda N; Konishi M; Takahashi S
J Surg Res; 2018 Jan; 221():15-23. PubMed ID: 29229121
[TBL] [Abstract][Full Text] [Related]
5. Complete circumferential lymphadenectomy around the superior mesenteric artery with preservation of nerve plexus reduces locoregional recurrence after pancreatoduodenectomy for resectable pancreatic ductal adenocarcinoma.
Hirono S; Kawai M; Okada KI; Miyazawa M; Kitahata Y; Kobayashi R; Hayami S; Ueno M; Yamaue H
Eur J Surg Oncol; 2021 Oct; 47(10):2586-2594. PubMed ID: 34127329
[TBL] [Abstract][Full Text] [Related]
6. Resection of pancreatic ductal adenocarcinoma with synchronous distant metastasis: is it worthwhile?
Buc E; Orry D; Antomarchi O; Gagnière J; Da Ines D; Pezet D
World J Surg Oncol; 2014 Nov; 12():347. PubMed ID: 25407113
[TBL] [Abstract][Full Text] [Related]
7. Clinical impacts of resection margin status and clinicopathologic parameters on pancreatic ductal adenocarcinoma.
Jamiyan T; Shiraki T; Kurata Y; Ichinose M; Kubota K; Imai Y
World J Surg Oncol; 2020 Jun; 18(1):137. PubMed ID: 32571348
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemoradiation therapy after pancreaticoduodenectomy in elderly patients with pancreatic adenocarcinoma.
Horowitz DP; Hsu CC; Wang J; Makary MA; Winter JM; Robinson R; Schulick RD; Cameron JL; Pawlik TM; Herman JM
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1391-7. PubMed ID: 20643511
[TBL] [Abstract][Full Text] [Related]
9. Proton Radiotherapy for Isolated Local Recurrence of Primary Resected Pancreatic Ductal Adenocarcinoma.
Mizumoto T; Terashima K; Matsuo Y; Nagano F; Demizu Y; Mima M; Sulaiman NS; Tokumaru S; Okimoto T; Toyama H; Fukumoto T
Ann Surg Oncol; 2019 Aug; 26(8):2587-2594. PubMed ID: 31147994
[TBL] [Abstract][Full Text] [Related]
10. Redefining the Positive Margin in Pancreatic Cancer: Impact on Patterns of Failure, Long-Term Survival and Adjuvant Therapy.
Osipov A; Nissen N; Rutgers J; Dhall D; Naziri J; Chopra S; Li Q; Hendifar AE; Tuli R
Ann Surg Oncol; 2017 Nov; 24(12):3674-3682. PubMed ID: 28871564
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors Associated With Early Recurrence of Borderline Resectable Pancreatic Ductal Adenocarcinoma After Neoadjuvant Chemoradiation Therapy and Curative Resection.
Tsuchiya N; Matsuyama R; Murakami T; Yabushita Y; Sawada YU; Kumamoto T; Endo I
Anticancer Res; 2019 Aug; 39(8):4431-4440. PubMed ID: 31366541
[TBL] [Abstract][Full Text] [Related]
12. Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience.
Cloyd JM; Katz MH; Prakash L; Varadhachary GR; Wolff RA; Shroff RT; Javle M; Fogelman D; Overman M; Crane CH; Koay EJ; Das P; Krishnan S; Minsky BD; Lee JH; Bhutani MS; Weston B; Ross W; Bhosale P; Tamm EP; Wang H; Maitra A; Kim MP; Aloia TA; Vauthey JN; Fleming JB; Abbruzzese JL; Pisters PW; Evans DB; Lee JE
J Gastrointest Surg; 2017 Jan; 21(1):164-174. PubMed ID: 27778257
[TBL] [Abstract][Full Text] [Related]
13. Impact of Margin Status on Survival in Patients with Pancreatic Ductal Adenocarcinoma Receiving Neoadjuvant Chemotherapy.
Schmocker RK; Delitto D; Wright MJ; Ding D; Cameron JL; Lafaro KJ; Burns WR; Wolfgang CL; Burkhart RA; He J
J Am Coll Surg; 2021 Apr; 232(4):405-413. PubMed ID: 33338577
[TBL] [Abstract][Full Text] [Related]
14. Intermediate results of extended pancreaticoduodenectomy. Verona experience.
Iacono C; Facci E; Bortolasi L; Zamboni G; Scarpa A; Talamini G; Prati G; Nifosà F; Serio G
J Hepatobiliary Pancreat Surg; 1999; 6(1):74-8. PubMed ID: 10436240
[TBL] [Abstract][Full Text] [Related]
15. Role of Adjuvant Chemoradiotherapy for Duodenal Cancer: An Updated Analysis of Long-Term Follow-Up from Single Institution.
Jang BS; Park HJ; Kim K; Jang JY; Kim SW; Oh DY; Chie EK
World J Surg; 2018 Oct; 42(10):3294-3301. PubMed ID: 29869181
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma in the Netherlands: A Nationwide Retrospective Analysis.
de Rooij T; Tol JA; van Eijck CH; Boerma D; Bonsing BA; Bosscha K; van Dam RM; Dijkgraaf MG; Gerhards MF; van Goor H; van der Harst E; de Hingh IH; Kazemier G; Klaase JM; Molenaar IQ; Patijn GA; van Santvoort HC; Scheepers JJ; van der Schelling GP; Sieders E; Busch OR; Besselink MG;
Ann Surg Oncol; 2016 Feb; 23(2):585-91. PubMed ID: 26508153
[TBL] [Abstract][Full Text] [Related]
17. Predictors of early recurrence following neoadjuvant chemotherapy and surgical resection for localized pancreatic adenocarcinoma.
Narayanan S; AlMasri S; Zenati M; Nassour I; Chopra A; Rieser C; Smith K; Oyefusi V; Daum T; Bahary N; Bartlett D; Lee K; Zureikat A; Paniccia A
J Surg Oncol; 2021 Sep; 124(3):308-316. PubMed ID: 33893740
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemoradiotherapy after pancreatic resection for invasive carcinoma associated with intraductal papillary mucinous neoplasm of the pancreas.
Swartz MJ; Hsu CC; Pawlik TM; Winter J; Hruban RH; Guler M; Schulick RD; Cameron JL; Laheru DA; Wolfgang CL; Herman JM
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):839-44. PubMed ID: 19647950
[TBL] [Abstract][Full Text] [Related]
19. Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma.
Cloyd JM; Crane CH; Koay EJ; Das P; Krishnan S; Prakash L; Snyder RA; Varadhachary GR; Wolff RA; Javle M; Shroff RT; Fogelman D; Overman M; Wang H; Maitra A; Lee JE; Fleming JB; Katz MH
Cancer; 2016 Sep; 122(17):2671-9. PubMed ID: 27243381
[TBL] [Abstract][Full Text] [Related]
20. The predictors and patterns of the early recurrence of pancreatic ductal adenocarcinoma after pancreatectomy: the influence of pre- and post- operative adjuvant therapy.
Suto H; Okano K; Oshima M; Ando Y; Takahashi S; Shibata T; Kamada H; Kobara H; Masaki T; Suzuki Y
BMC Surg; 2019 Dec; 19(1):186. PubMed ID: 31796066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
